CRIS Current Research Information System

VITALI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.811
AS - Asia 12.202
NA - Nord America 11.581
AF - Africa 937
SA - Sud America 638
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 10
Totale 43.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.391
IT - Italia 10.087
CN - Cina 3.268
SG - Singapore 3.197
VN - Vietnam 2.735
GB - Regno Unito 2.122
DE - Germania 1.212
SE - Svezia 911
HK - Hong Kong 906
FR - Francia 726
IN - India 619
NL - Olanda 523
BR - Brasile 452
RU - Federazione Russa 447
UA - Ucraina 380
IE - Irlanda 300
KR - Corea 256
JP - Giappone 242
CI - Costa d'Avorio 227
ZA - Sudafrica 223
PK - Pakistan 171
FI - Finlandia 166
TG - Togo 144
CH - Svizzera 120
EE - Estonia 113
CA - Canada 108
ID - Indonesia 107
PL - Polonia 97
NG - Nigeria 93
SC - Seychelles 92
BE - Belgio 89
AR - Argentina 85
ES - Italia 77
PH - Filippine 75
TR - Turchia 74
BG - Bulgaria 71
TH - Thailandia 67
IR - Iran 66
JO - Giordania 66
GR - Grecia 62
TW - Taiwan 57
IQ - Iraq 55
BD - Bangladesh 54
HR - Croazia 52
EG - Egitto 49
MX - Messico 45
AT - Austria 41
DZ - Algeria 36
RO - Romania 33
SA - Arabia Saudita 31
MY - Malesia 28
UZ - Uzbekistan 28
CL - Cile 27
AU - Australia 26
DK - Danimarca 21
PT - Portogallo 21
LB - Libano 18
SM - San Marino 18
CZ - Repubblica Ceca 17
MA - Marocco 17
CO - Colombia 16
LT - Lituania 15
RS - Serbia 15
PE - Perù 14
SK - Slovacchia (Repubblica Slovacca) 14
EC - Ecuador 12
NO - Norvegia 12
VE - Venezuela 11
AL - Albania 10
HU - Ungheria 10
IL - Israele 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
GH - Ghana 8
KZ - Kazakistan 8
TN - Tunisia 8
ET - Etiopia 7
KE - Kenya 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
BB - Barbados 6
OM - Oman 6
SI - Slovenia 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CM - Camerun 4
JM - Giamaica 4
LU - Lussemburgo 4
MT - Malta 4
QA - Qatar 4
BZ - Belize 3
GE - Georgia 3
KH - Cambogia 3
KW - Kuwait 3
Totale 43.143
Salva come PNG Salva come JPEG
Città #
Singapore 2.169
Southend 1.762
Ashburn 1.302
Bologna 883
Hong Kong 830
Chandler 817
Fairfield 759
Milan 738
Rome 672
San Jose 623
Ho Chi Minh City 617
Hefei 548
Hanoi 527
Santa Clara 508
Wilmington 423
Ann Arbor 384
Seattle 381
Princeton 379
Beijing 367
Woodbridge 362
Houston 344
Dublin 289
Cambridge 286
Frankfurt am Main 280
Boardman 272
Dallas 256
Naples 255
Los Angeles 249
Abidjan 227
Seoul 222
Dong Ket 218
Lauterbourg 206
Turin 201
Jacksonville 192
Padova 192
Florence 181
Tokyo 181
Nanjing 179
Westminster 156
New York 152
Council Bluffs 147
Lomé 144
Berlin 141
Helsinki 121
Buffalo 106
Modena 105
Jinan 102
Bari 97
Da Nang 97
Catania 95
Redmond 92
Medford 85
Saint Petersburg 85
Shanghai 85
Cesena 84
Guangzhou 84
Palermo 82
Shenyang 80
Haiphong 78
Lahore 73
Redondo Beach 73
Abeokuta 72
Bengaluru 67
Sofia 67
Dearborn 66
Nanchang 66
San Diego 66
Tianjin 65
Amman 64
Munich 62
São Paulo 61
Changsha 59
Johannesburg 59
Amsterdam 57
Hebei 56
Verona 56
Falls Church 54
Bern 52
Brussels 52
Jakarta 52
Gujranwala 49
Orem 48
Chicago 47
Pescara 47
Redwood City 47
Parma 46
Genoa 45
London 45
Mülheim 45
Perugia 45
Zhengzhou 43
Hangzhou 39
Warsaw 39
Forlì 38
Cagliari 37
Des Moines 37
Phoenix 36
The Dalles 35
Hyderabad 34
Mumbai 33
Totale 23.633
Salva come PNG Salva come JPEG
Nome #
VSL#3 in gravidanza: impatto sul microbiota e sulla risposta immune vaginale 6.743
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 714
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 673
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 669
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 482
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 336
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 322
Inserti vaginali mucoadesivi costituiti da complessi di chitosano e alginato per il rilascio locale di clorexidina digluconato 311
Identification of vaginal bacteria 298
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 291
Isolation of vaginal lactobacilli and characterization of anti-candida activity 289
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 283
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 280
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 267
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 255
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 254
Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration 252
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 247
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota 242
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 239
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity 239
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 239
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 236
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 230
Characterization and Heterologous Expression of the Oxalyl Coenzyme A Decarboxylase Gene from Bifidobacterium lactis 225
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 222
Diversity of vaginal microbiome and metabolome during genital infections 221
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 220
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 216
Development of azithromycin-loaded microemulsions for the treatment of skin infections 213
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina 213
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR 212
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 210
Investigation on the effects of antimicrobial imidazo[2,1-b]thiazole derivatives on the genitourinary microflora 209
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali 207
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 207
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 207
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 207
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 206
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 205
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 205
High-dose probiotics for the treatment of active pouchitis 204
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 204
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system 203
Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate 200
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 198
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 197
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 197
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 197
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 197
Novel probiotic candidates for humans isolated from raw fruits and vegetables 195
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 195
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 194
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 191
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 189
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 188
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 183
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride 183
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 181
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy 180
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system-authors' response 180
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 179
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion 177
In-vitro effect of vaginal lactobacilli against group B Streptococcus 177
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens 176
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 176
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 175
A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry 174
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 173
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 170
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. 167
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 166
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 166
Human Breast Milk: A Source of Potential Probiotic Candidates 166
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 165
Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo 165
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 165
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota 164
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 164
High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. 163
Correlation of Atopobium vaginae amount with bacterial vaginosis markers 163
Method for diagnosis vaginal infections 163
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 163
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 163
Protocol for the Use of PCR-Denaturing Gradient Gel Electrophoresis and Quantitative PCR to Determine Vaginal Microflora Constitution and Pathogens in Bacterial Vaginosis 162
Metabolic profiling of Candida clinical isolates of different species and infection sources 162
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real time PCR study 161
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis 160
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 160
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 157
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 157
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 157
Bifidobacterium lactis Enolase, surface localization and mechanism of interaction with human Plasminogen 156
null 156
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 156
Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate 155
Designing fermented milk with targeted probiotics: a step toward female-focused functional foods 154
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 154
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 154
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 154
Totale 28.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.299 0 0 0 0 0 0 0 0 0 204 219 876
2021/20224.084 336 194 237 241 434 253 201 307 200 312 769 600
2022/20235.233 492 619 271 542 391 417 289 334 801 284 446 347
2023/20243.488 250 348 273 319 314 526 228 202 204 337 237 250
2024/20258.160 446 942 817 661 1.014 534 851 470 338 495 466 1.126
2025/202613.849 1.248 1.478 1.331 1.112 1.531 868 1.977 681 2.577 1.046 0 0
Totale 44.030